Selzentry: Anti – AIDS Drug

Pfizer on Tuesday unveiled a new drug test results. This anti –AIDS drug is said will help patients to stay healthier for longer periods. Selzentry is the first new class of oral HIV medicines to be introduced in more than 10 years. After 48 weeks of trial nearly three times as many patients receiving the drug combined with traditional medication recorded undetectable levels of HIV compared to those not receiving the drug. The safety and durability of the drug is a concern but till date adverse effects within dosage schedule is very less. This drug may turn to be a boon for curing HIV